Douglas A. Corley

Jul 19, 2024 | jamanetwork.com | Chyke A. Doubeni |Douglas A. Corley |Christopher Jensen |Theodore Levin

Key PointsQuestion  What is the colorectal cancer mortality benefit of screening with fecal immunochemical tests (FITs)? Findings  In this nested case control study of 10 711 individuals, completing a FIT to screen for colorectal cancer was associated with a reduction in risk of dying from colorectal cancer of approximately 33% overall, and there was a 42% lower risk for left colon and rectum cancers.

Apr 22, 2023 | giejournal.org | Douglas A. Corley |Christopher Jensen |Jeffrey Lee |Joanne E Schottinger

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.